Actively Recruiting
Effects of Sensorimotor Training With Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Patients
Led by Riphah International University · Updated on 2024-12-17
24
Participants Needed
2
Research Sites
45 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Chemotherapy-Induced Peripheral Neuropathy (CIPN) is a prevalent and clinically relevant side effect of chemotherapy in breast cancer patients. It occurs in 30-70% of cases. It can cause various sensory and motor symptoms. Specific exercise interventions have proven promising to target relevant symptoms. Therefore, the objective of this study is to determine the effects of Sensorimotor training on pain intensity, perceived balance confidence, and functional exercise capacity with chemotherapy-induced peripheral neuropathy in breast cancer patients.
CONDITIONS
Official Title
Effects of Sensorimotor Training With Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female with invasive ductal carcinoma, stages I-III
- Age between 30 and 65 years
- 3 to 6 months post breast cancer diagnosis
- Completed chemotherapy treatment and medically stable
- Chemotherapy-induced peripheral neuropathy symptoms assessed by FACT/GOG-Ntx score between 0 and 44
- Balance impairment with Fullerton Advanced Balance scale score 625 out of 40
- Objective neurological testing including tendon reflexes, sensitivity, touch perception, position sense, and lower leg strength assessed by Likert-scale
You will not qualify if you...
- Presence of other types of cancer besides breast cancer
- Chronic medical conditions such as poorly controlled diabetes
- Significant neurological diseases like multiple sclerosis
- Cardiopulmonary disease including myocardial infarction within the last 3 months
- Unstable bone metastasis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Mayo Hospital Lahore
Lahore, Punjab Province, Pakistan, 54000
Actively Recruiting
2
Mayo Hospital
Lahore, Punjab Province, Pakistan, 54000
Actively Recruiting
Research Team
I
Imran Amjad, PHD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here